





Yifan Pharmaceutical Co.,Ltd. - CDMO/CMO
YiFan Pharmaceutical Co., Ltd. – Your Trusted Partner in Advanced Pharmaceutical Solutions
As a leading CDMO and a publicly listed company on China's stock exchange, YiFan Pharmaceutical Co., Ltd. specializes in delivering end-to-end services for the development and production of high-quality API in the macromolecule bio pharmaceutical sector. With a focus on innovation, precision, and global compliance, we empower biotech and pharmaceutical companies to bring life-changing therapies to market efficiently and reliably.
Expertise in Macromolecule bio Pharma API Production
We excel in the complex synthesis of biologics and peptides, offering unparalleled expertise in:
Human Growth Hormones (HGH)
Insulin Analogues (e.g., rapid-acting, long-acting variants)
Metabolic Peptides: Teriparatide, Semaglutide, Liraglutide
Tool...

China

20+ years’ expertise in API manufacturing, trusted for quality and global compliance.

Listed pharma leader in China, prioritizing transparency and regulatory excellence.

End-to-end integration from R&D to scalable production, delivering cost-efficient solutions.
Our services:
Production scale:
Response time:
Upcoming events

CPHI China 2025
In-person eventBooth: W3G58 Jun 24-26,2025 Shanghai,China Welcome to visit Yifan Pharma
24-06-2025
Learn more
CPHI Worldwide 2025 11.0G58
In-person eventWelcome to meet Yifan at CPHI WW 2025 Booth: 11.0G58 Otc. 28-30,2025 Frankfurt
28-10-2025
Learn more
Services
Drug Substance (CDMO/CRO)
Replies quickly
Contact Yifan Pharmaceutical Co.,Ltd. for Contract Services Expertise
Connect with Yifan Pharmaceutical Co.,Ltd., a leading pharmaceutical company from China. They offer specialized Drug Substance (CDMO/CRO), of which the services for CMO/CDMO include Powders & Granules. Contact Yifan Pharmaceutical Co.,Ltd. for free and discover if they are the perfect partner for your pharmaceutical needs.
Drug Substance (CDMO/CRO)
Drug Substance CDMOs and CROs provide essential services in the development and manufacturing of active pharmaceutical ingredients (APIs). These organizations specialize in early-stage research, process development, and GMP-compliant manufacturing of drug substances for clinical and commercial use.
Pharmaoffer's Drug Substance CDMO/CRO category includes partners with expertise in small molecules, biologics, peptides, and complex chemistry, all operating under strict regulatory compliance. These providers help companies scale from lab to market efficiently and cost-effectively.
Key Functions of Drug Substance CDMOs/CROs:
API Research and Development: Providing early-stage discovery support, custom synthesis, and process optimization to streamline the development of drug substances.
Process Scale-Up and Tech Transfer: Transitioning from bench-scale to pilot and commercial scale production with validated methods and reproducibility.
GMP Manufacturing: Delivering high-quality API batches in GMP-certified environments, adhering to FDA, EMA, and other international standards.
Analytical Services: Offering comprehensive analytical method development and validation to ensure consistent quality and regulatory compliance.
Flexible and Specialized Capabilities: From small molecule synthesis to biologic and peptide manufacturing, these partners provide specialized services tailored to product-specific needs.
Explore Leading API CDMOs and CROs
Pharmaoffer connects you with trusted CDMOs and CROs for drug substance development. Our platform enables seamless access to specialized service providers equipped to support your API lifecycle from discovery to commercialization.
Oral solid products
Oral solid products include tablets and capsules. CMOs provide formulation development, manufacturing, and packaging of solid dosage forms.
Powders & Granules
Powders and granules are flexible oral formats. CMOs support blending, granulation, and GMP filling for pharmaceutical applications.